Latest Payments News

Cazaly Resources reports solid exploration progress across copper, zinc, lithium, and rare earth projects in Australia, Namibia, and Canada, supported by a stable cash position of $3.8 million at December 2024.

Hexima Limited has called off its planned acquisition of AI developer Real Thing Entertainment, ending the quarter with $1.64 million in cash and a cautious outlook on future strategic moves.

Health and Plant Protein Group Limited reported a decline in cash reserves to $0.90 million for Q2 FY25, continuing its efforts to resolve a US tax withholding issue tied to a previous asset sale.

Dreadnought Resources reported a challenging quarter with significant exploration spending and a tight cash position, yet remains confident in its operational outlook and funding prospects.

Site Group International edges closer to securing a pivotal Higher Training Institute license in Saudi Arabia, while reporting a robust 112% revenue surge and completing a $1 million capital raise to fuel expansion.

Fin Resources Limited reports steady progress in lithium and uranium exploration across its Canadian and Australian projects, while managing a lean cash position and evaluating funding options.

Clean TeQ Water Limited reports a landmark $11 million contract for its PHOSPHIX® phosphate removal plant in Ireland, alongside successful project deliveries and lithium recovery breakthroughs, setting the stage for improved financial performance in 2025.

Culpeo Minerals Limited reported a net cash outflow of $246,000 for the December 2024 quarter but retains robust liquidity with $3.7 million in available funding. The company’s cash position and financing facilities suggest it is well-positioned to continue its exploration activities.

Western Gold Resources Limited has secured expanded mining approvals, confirmed strong metallurgical recoveries, and updated its mineral resource estimate at the Gold Duke Project, positioning the company for a transition to production.

HALO Technologies reports a robust 45.5% increase in operating revenue for 2024, driven by surging Funds Under Management and brokerage income, while advancing its UK market entry alongside a $6.75 million capital raise.

Peppermint Innovation Ltd has bolstered its financial position with a $3 million convertible note while navigating a challenging quarter marked by cybersecurity disruptions and strategic divestments. The company is poised for recovery with new advisory expertise and enhanced payment integrations in the Philippines.

Paradigm Biopharmaceuticals has launched a Loyalty and Piggyback Options program aimed at rewarding shareholders and raising up to $111.96 million to support its pivotal Phase III clinical trial.